Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Series X convertible preferred stock [Member]	Series A Convertible Preferred Stock
Balance, shares at Dec. 31, 2021		140,200
Balance, amount at Dec. 31, 2021	$ 13,673	$ 0	$ 191,945	$ (178,272)	$ 0	$ 0
Common stock and warrants issued, net, shares		504,958
Common stock and warrants issued, net, amount	9,740	$ 0	9,740	0	0	0
Warrants exercised, shares		1,000
Warrants exercised, amount	25	$ 0	25	0	0	0
Vesting of restricted stock units and awards, shares		159
Vesting of restricted stock units and awards, amount	0	$ 0	0	0	0	0
Restricted stock awards cancelled, shares		(289)
Restricted stock awards cancelled, amount	0	$ 0	0	0	0	0
Stock-based compensation	165	0	165	0	0	0
Net loss	(5,495)	$ 0	0	(5,495)	0	0
Balance, shares at Mar. 31, 2022		646,028
Balance, amount at Mar. 31, 2022	18,108	$ 0	201,875	(183,767)	0	0
Balance, shares at Dec. 31, 2021		140,200
Balance, amount at Dec. 31, 2021	13,673	$ 0	191,945	(178,272)	0	0
Net loss	(13,943)
Balance, shares at Jun. 30, 2022		646,578
Balance, amount at Jun. 30, 2022	9,791	$ 0	202,006	(192,215)	0	0
Balance, shares at Mar. 31, 2022		646,028
Balance, amount at Mar. 31, 2022	18,108	$ 0	201,875	(183,767)	0	0
Restricted stock awards cancelled, shares		(701)
Restricted stock awards cancelled, amount	0	$ 0	0	0	0	0
Stock-based compensation	126	$ 0	126	0	0	0
Net loss	(8,448)			(8,448)		0
Common stock issued pursuant to the vesting of restricted stock units and purchased under the employee stock purchase plan, shares		1,251
Common stock issued pursuant to the vesting of restricted stock units and purchased under the employee stock purchase plan, amount	5	$ 0	5	0	0	0
Balance, shares at Jun. 30, 2022		646,578
Balance, amount at Jun. 30, 2022	9,791	$ 0	202,006	(192,215)	0	0
Balance, shares at Dec. 31, 2022		2,161,288
Balance, amount at Dec. 31, 2022	9,260	$ 0	214,397	(205,137)	0	0
Restricted stock awards cancelled, shares		(363)
Restricted stock awards cancelled, amount	0	$ 0	0	0	0	0
Stock-based compensation	1,394	0	1,394	0	0	0
Net loss	(66,400)	$ 0	0	(66,400)	0	0
Common stock issued upon the exercise of options, shares		301,746
Common stock issued upon the exercise of options, amount	179	$ 0	179	0	$ 0	0
Issuance of Series X Convertible Preferred Stock in merger, shares					14,650
Issuance of Series X Convertible Preferred Stock in merger, amount	82,925	$ 0	82,925	0	$ 0	0
Conversion of Series X Convertible Preferred Stock, shares		1,974,905			(1,975)
Conversion of Series X Convertible Preferred Stock, amount	0	$ 0	0	0	$ 0	$ 0
Issuance of Series A Convertible Preferred Stock in connection with private placement, net, shares		497,908				7,203
Issuance of Series A Convertible Preferred Stock in connection with private placement, net, amount	7,360	$ 0	7,360	0	0	$ 0
Warrants exercised, shares		331,608
Warrants exercised, amount	1,145	$ 0	1,145	0	$ 0	$ 0
Balance, shares at Mar. 31, 2023		5,267,092			12,675	7,203
Balance, amount at Mar. 31, 2023	35,863	$ 0	307,400	(271,537)	$ 0	$ 0
Balance, shares at Dec. 31, 2022		2,161,288
Balance, amount at Dec. 31, 2022	9,260	$ 0	214,397	(205,137)	$ 0	$ 0
Net loss	(67,976)
Balance, shares at Jun. 30, 2023		5,367,674			12,675	7,203
Balance, amount at Jun. 30, 2023	23,791	$ 0	296,904	(273,113)	$ 0	$ 0
Balance, shares at Mar. 31, 2023		5,267,092			12,675	7,203
Balance, amount at Mar. 31, 2023	35,863	$ 0	307,400	(271,537)	$ 0	$ 0
Net loss	(1,576)	$ 0	0	(1,576)	0	0
Common stock issued upon the exercise of options, shares		100,582
Common stock issued upon the exercise of options, amount	59	$ 0	59	0	0	0
Adjustment of fair value of Series X Convertible Preferred stock in merger	(10,381)	0	(10,381)	0	0	0
Adjustment of fair value Stock-based compensation related to merger	(174)	$ 0	(174)	0	$ 0	$ 0
Balance, shares at Jun. 30, 2023		5,367,674			12,675	7,203
Balance, amount at Jun. 30, 2023	$ 23,791	$ 0	$ 296,904	$ (273,113)	$ 0	$ 0